NCT00698204View on ClinicalTrials.gov

Cox-2 Inhibition in Radiation-induced Oral Mucositis

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2013

Conditions
Oral Mucositis
Interventions
DRUG

celecoxib

Subject was asked to take celecoxib each day that radiation therapy was given.

DRUG

placebo

Subject was asked to take placebo each day that radiation therapy was given.

Trial Locations (2)

06030-1605

University of Connecticut Health Center, Farmington

06102

Hartford Hospital, Hartford

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

collaborator

Pfizer

INDUSTRY

lead

UConn Health

OTHER